Journal of Nuclear Medicine September 2024, jnumed.124.267624; DOI: https://doi.org/10.2967/jnumed.124.267624 ...

Journal of Nuclear Medicine September 2024, jnumed.124.267964; DOI: https://doi.org/10.2967/jnumed.124.267964 ...

Journal of Nuclear Medicine September 2024, jnumed.124.267751; DOI: https://doi.org/10.2967/jnumed.124.267751 ...

Paraplegic Patient with Metastatic Papillary Thyroid Cancer: A Multidisciplinary Approach to Radioactive Iodine Therapy Safety and Efficacy Strategy ...

Objectives Many incidental colorectal lesions with focal FDG uptake discovered on F-18 FDG PET/CT performed for an unrelated reason are neoplastic, often malignant. There is paucity of data on the PET ...

Dual Somatostatin Receptor/ 18 F-FDG PET/CT Imaging in Patients with Well-Differentiated, Grade 2 and 3 Gastroenteropancreatic Neuroendocrine Tumors ...

Objectives Stimulant medications (methylphenidate and amphetamine) are the treatments of choice in ADHD and are believed to acutely compensate for a chronic dopamine (DA) deficit in this disorder.

Journal of Nuclear Medicine August 2024, jnumed.124.267685; DOI: https://doi.org/10.2967/jnumed.124.267685 ...

Objectives There are numerous reports in the medical literature of false positive foci in post-therapy I-131 images in thyroid cancer patients. These include: mucocele, pleural effusion, pericardial ...

Journal of Nuclear Medicine March 2006, 47 (3) 554-555; It might therefore be useful if the reading of both planar and tomographic (SPECT) scintimammography studies incorporated not only the typically ...

Objectives [18 F]CFpyPB is a potent and selective PET tracer for GlyT1 which has been implicated in schizophrenia pathophysiology. Preliminary human dosimetry and brain tracer kinetics is presented.